Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (151-160 of 377) with videos related to

Pageof 38
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Critical Reviews in Oncology/Hematology|December 8, 2015
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trialsFrancesco Massari, Alessandra Modena, Chiara Ciccarese, et al.
Cancer|October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategiesFotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.
Mediators of Inflammation|December 13, 2019
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung CancerCarmine Carbone, Geny Piro, Vincenzo Di Noia, et al.
Reviews on Recent Clinical Trials|May 20, 2022
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?Filippo Lococo, Marco Chiappetta, Corolina Sassorossi, et al.
Frontiers in Oncology|April 27, 2019
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival MelanomaErnesto Rossi, Brigida Anna Maiorano, Monica Maria Pagliara, et al.
Cancers|April 3, 2021
Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant TherapyMarco Chiappetta, Filippo Lococo, Giovanni Leuzzi, et al.
World Journal of Gastrointestinal Surgery|October 8, 2021
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinomaIlaria Trestini, Marco Cintoni, Emanuele Rinninella, et al.
Breast (Edinburgh, Scotland)|October 18, 2016
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatmentLaura Orlando, Giuseppe Viale, Emilio Bria, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 10, 2020
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapyMarco Chiappetta, Filippo Lococo, Giovanni Leuzzi, et al.
Pageof 38

Showing results (151-160 of 377) with videos related to

Sort By:
Pageof 38
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Critical Reviews in Oncology/Hematology|December 8, 2015
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trialsFrancesco Massari, Alessandra Modena, Chiara Ciccarese, et al.
Cancer|October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategiesFotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.
Mediators of Inflammation|December 13, 2019
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung CancerCarmine Carbone, Geny Piro, Vincenzo Di Noia, et al.
Reviews on Recent Clinical Trials|May 20, 2022
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?Filippo Lococo, Marco Chiappetta, Corolina Sassorossi, et al.
Frontiers in Oncology|April 27, 2019
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival MelanomaErnesto Rossi, Brigida Anna Maiorano, Monica Maria Pagliara, et al.
Cancers|April 3, 2021
Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant TherapyMarco Chiappetta, Filippo Lococo, Giovanni Leuzzi, et al.
World Journal of Gastrointestinal Surgery|October 8, 2021
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinomaIlaria Trestini, Marco Cintoni, Emanuele Rinninella, et al.
Breast (Edinburgh, Scotland)|October 18, 2016
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatmentLaura Orlando, Giuseppe Viale, Emilio Bria, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 10, 2020
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapyMarco Chiappetta, Filippo Lococo, Giovanni Leuzzi, et al.
Pageof 38